BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 

Rigel 

Massachusetts Life Sciences Center 





 Company News
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each 5/20/2015 6:44:18 AM
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV) 5/19/2015 3:42:55 PM
Decision Diagnostics States Johnson & Johnson (JNJ) Division Offers Partial Surrender In Long Running Patent Battle 5/19/2015 11:45:32 AM
Johnson & Johnson (JNJ) Commits $25 Million To Operation Smile Over Next Five Years 5/19/2015 10:34:12 AM
New FDA Warning Impacts Diabetes Drugs Made by AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) and Eli Lilly (LLY) 5/18/2015 6:40:10 AM
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/14/2015 7:04:28 AM
Johnson & Johnson (JNJ)’s Piping Hot Pipeline 5/13/2015 6:35:23 AM
Johnson & Johnson (JNJ) Expands IP Policy To Create Broad Access In 128 Countries For Development Of New And Optimized HIV Medicine Formulations For Children Living With HIV 5/11/2015 6:44:01 AM
Johnson & Johnson (JNJ) Taps Ethicists to Weigh Compassionate Use Requests 5/7/2015 5:52:54 AM
Johnson & Johnson (JNJ) Eyes $300 Million Expansion &100 New Jobs in Florida 5/7/2015 5:48:51 AM
12345678910...